Barron's | Financial and Investment News

Time 2021-01-13 22:11:49

Web Name: Barron's | Financial and Investment News

WebSite: http://topics.barrons.com

ID:166269

Keywords:

Financial,Barron,and,

Description:

EnergyØrsted Stock Falls as Slower Wind Speeds Will Hit 2021 Earnings The Danish energy giant has disappointed investors with its early outlook for 2021.3 min FinTechVisa-Plaid Merger Had Wall Street Excited. With Deal Called Off, Reappraisals Are Coming. Payments technology merger is abandoned in the face of antitrust opposition. 2 min MarketsPodcast: 393,000 Americans Laid Off From Restaurants and Hotels in November More high-yield debt is defaulting, hospitality workers are hit hard, and Brazil’s government is spending big.2 min MediaTwitter Is Still Facing Fallout From Banning Trump. Here’s the Latest Wall Street Call. Rosenblatt Securities analyst Mark Zgutowicz says 2021 ad sales could come in at $3.28 billion, well below the consensus estimate of $3.83 billion.2 min 5GWhat a Record-Breaking 5G Auction Means for AT T, Verizon and T-Mobile “We continue to argue that carriers can’t overspend on this spectrum,” wrote New Street analyst Jonathan Chaplin on Monday.4 min TechnologyAuto Chip Shortage Will Slow Car Makers, Analog Devices CEO Says Auto chip shortages are due to the increased volume of chips per car, and a delay in restarting production to meet the surge in demand, says the Analog Devices CEO.2 min Value InvestingWells Fargo, Bank of America, and FedEx Are Too Popular With Investors. Other Stocks Could Pop, Citi Says. In a survey of stocks that are widely held by investors, Citigroup sees signs of a rotation into value stocks that could continue. 3 min OptionsBank of America Stock Could Pop on Earnings. How to Play the Results. Use this options strategy to bullishly position of the bank’s fourth-earnings on Jan. 19.2 min Biotech and PharmaWhat Eli Lilly’s Good News About Its Alzheimer’s Drug Means for Biogen Eli Lilly’s optimistic results for its Alzheimer’s drug in a clinical trial is a good sign for rival Biogen, which is looking for its similar drug to be approved. 3 min Biotech and PharmaBristol Myers Looks to Drug Pipeline to Turbocharge Growth The drugmaker expects its current pipeline of drugs could generate $25 billion in annual revenue and sees opportunities for more acquisitions.2 min IPOsMytheresa and loanDepot Join IPO Pipeline. SoftBank-Backed Compass Files Confidentially. Three more high-profile companies announced plans to go public: Luxury fashion site Mytheresa, lender loanDepot, and real estate tech firm Compass.3 min ConsumerBest Buy’s CEO Flags Pandemic’s Lessons for Retailers Corie Barry became Best Buy’s CEO less than a year before the pamdemic hit. She weighed in on the outlook at this year’s virtual CES.2 minWhy Walmart Is Creating a Fintech Start-Up Company is taking another step to push beyond retail.2 min How Target Can Keep Beating Expectations Target had a great 2020; and Credit Suisse argues that momentum should carry into this year when the big retailer discloses preliminary results for the December holidays.2 min ColumnistsPierre BriançonFeatureA New ‘Big Bang’ for the City of London? Wrong Idea.Al RootStreet NotesBuy Ballard Stock Because 2021 Could Be Big For Hydrogen TechnologiesCarleton EnglishPower PlayActivists Are Primed for Action in 2021

TAGS:Financial Barron and 

<<< Thank you for your visit >>>

Barron's is a leading source of financial news, providing in-depth analysis and commentary on stocks, investments and how markets are moving across the world.

Hot Websites